Metrics
- Price
- $59.01
- Market Cap $M
- 3,594
- Rel Volume
- 0.43
- Vol Up 2W
- 55.60%
- Vol Trend 2W
- -35.50%
- 1D
- +1.99%
- 1W
- -2.46%
- 1M
- -1.16%
- 1M Slope
- -0.77%
- 6M Range
- 124.40%
- Score
- 81.6
- Sharp
- 3.4
Volume
Profile
Enliven Therapeutics is a biotechnology company developing targeted small-molecule therapies for cancer, with a focus on precision oncology drug candidates.
Biotech
Pharmaceuticals